Dual scrutiny by the Brazilian Patent and Trademark Office and Health Regulatory Agency demands careful coordination to avoid rejected brands or delayed products.
Dual scrutiny by the Brazilian Patent and Trademark Office and Health Regulatory Agency demands careful coordination to avoid rejected brands or delayed products.